↓ Skip to main content

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

Overview of attention for article published in Clinical Epigenetics, January 2017
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
40 Mendeley